Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer

Informacje na temat projektu

NANOBIO4CAN

Identyfikator umowy o grant: 101126492

DOI

10.3030/101126492

Data podpisania przez KE 18 Września 2023

Data rozpoczęcia 1 Listopada 2023

Data zakończenia 31 Października 2028

Finansowanie w ramach

• Marie Skłodowska-Curie Actions (MSCA)

Koszt całkowity

Brak danych

Wkład UE

€ 2 292 480,00

Koordynowany przez

SABANCI UNIVERSITESI NANOTEKNOLOJI ARASTIRMA VE UYGULAMA MERKEZI SUNUM
Türkiye

CORDIS oferuje możliwość skorzystania z odnośników do publicznie dostępnych publikacji i rezultatów projektów realizowanych w ramach programów ramowych HORYZONT.

Odnośniki do rezultatów i publikacji związanych z poszczególnymi projektami 7PR, a także odnośniki do niektórych konkretnych kategorii wyników, takich jak zbiory danych i oprogramowanie, są dynamicznie pobierane z systemu OpenAIRE .

Rezultaty

Other (2)

Call 2 – Link to Euraxess website

Inform the Project Officer on publishing each call for proposals, by sending the link to the Euraxess website and a screen shot of the related call announcement.

Call 1 – Link to Euraxess website

Inform the Project Officer on publishing each call for proposals, by sending the link to the Euraxess website and a screen shot of the related call announcement.

Documents, reports (1)

Call 1 – Report on dissemination activities

Dates/Interval of call publication and dissemination channels/means (supporting documents are required as images, screen shots, photos from events).Flyers, brochures, or other information produced for dissemination of the callPresentations held at conferences and/or meetings and/or other eventsArticles published in the press (please list and attach only main articles)Any other means for advertising the programme

Publikacje

Conference proceedings (9)

DISSECTING TUMOR IMMUNE MICROENVIRONMENT IN HOSPITALIZED LUNG CANCER PATIENTS

Autorzy: Saif Ullah Afridi, Devrim Gözüaçık, Abdullah Karadağ
Wydawca: Gebze Technical University
DOI: 10.5281/ZENODO.20818489

Hyaluronic acid-functionalized CaCO₃ crystals as novel polyelectrolytemultilayer reservoirs for CPT-RB (Chemotherapy and Photodynamictherapy) targeting multiple myeloma

Autorzy: Nemany Hanafy, Safacan Kölemen
Wydawca: MDPI, The publisher of the Sciforum.net Platform
DOI: 10.5281/ZENODO.20818713

Synthesis and Engineering of Redox-Active NanoMOFs For PDT: A Step Towards Light-Triggered Cancer Therapeutics

Autorzy: Ankush Sontakke, Funda Acar Yağcı
Wydawca: NanoTR: Nanoscience and Nanotechnology Community
DOI: 10.5281/ZENODO.20817678

Photodynamic therapy combined with chemotherapy represents a novel strategy in multiple myeloma treatment: Nano-Multilayered strategy

Autorzy: A.N. Hanafy, Nemany, Kolemen, Safacan
Wydawca: Acıbadem Mehmet Ali Aydınlar University, In the framework of the International Day of Light 2026
DOI: 10.5281/ZENODO.21929621

Strain Development of Pichia Pastoris with Knockout of Calcium and Manganese Transporting ATPase (GDT1 and PMR1) Gene Through CRISPR-Cas9 Editing

Autorzy: Noor Hamizah Binti Suhaimi, Mehmet İnan
Wydawca: Zenodo
DOI: 10.5281/ZENODO.20818812

Functionalization of CaCO₃ crystals as novel polyelectrolyte multilayer reservoir for drug delivery

Autorzy: Nemany Hanafy, Safacan Kölemen
Wydawca: NanoTR: Nanoscience and Nanotechnology Community
DOI: 10.5281/ZENODO.20818077

REASSESSING THE ROLE OF ANTIGEN PROCESSING MACHINERY IN NEXTGENERATION PRECISION MEDICINE

Autorzy: Ika Nurlaila,Abdullah Karadağ
Wydawca: Gebze Technical University
DOI: 10.5281/ZENODO.20818120

Optimization of Soysaponin-Carbon Quantum Dots as Naturally Derived and Cost-Effective Theranostic CQDs for Targeted Imaging of Cancer Cells

Autorzy: Nemany Hanafy, Safacan Kölemen
Wydawca: NanoTR: Nanoscience and Nanotechnology Community
DOI: 10.5281/ZENODO.20818048

PB41 İN VİVO AKCİĞER TÜMÖR MİKROÇEVRESİNİ İNCELEMEK İÇİN TEKRARLANABİLİR YÖNTEM: ASPİRASYONLA OLUŞTURULAN ORTOTOPİK AKCİĞER KANSER MODELİ

Autorzy: Müge Özkan, Bilgi Güngör
Wydawca: XXVII. Ulusal İmmünoloji Kongresi
DOI: 10.5281/ZENODO.20818580

Other (1)

Molecular markers: BCL10

Autorzy: AFRIDI, SAIFULLAH, Karadag, Abdullah
Wydawca: PathologyOutlines.com
DOI: 10.5281/ZENODO.21470252

Peer reviewed articles (4)

Antibacterial Efficacy of Ti3C2Tx and Nb2CTx MXenes Against Gram-Positive and Gram-Negative Bacterial Strains

Autorzy: Mina Masoudi, Mina Namvari
Wydawca: NanoTR: Nanoscience and Nanotechnology Community
DOI: 10.5281/ZENODO.20817968

RSC Advances

Autorzy: Nemany A. N. Hanafy, Safacan Kolemen
Opublikowane w: RSC Advances, Numer 16, 2026, ISSN 2046-2069
Wydawca: Royal Society of Chemistry
DOI: 10.1039/D5RA09823H

Spectral characterization and development of UV, direct fluorescence, and RP-HPLC-FLD assays for quantifying the BUB1 inhibitor BAY-1816032 in serum to support preclinical development

Autorzy: Fazel Gorjipour, Serif Senturk
Opublikowane w: Results in Chemistry, Numer 29, 2026, ISSN 2211-7156
Wydawca: Elsevier BV
DOI: 10.1016/J.RECHEM.2026.103693

Peptide-Functionalized Liposomal Nanocarriers for Targeted Therapy of Liver Fibrosis and Hepatocellular Carcinoma: Design, Mechanisms, and Clinical Prospects

Autorzy: Kashif Maroof, Ronald Fook Seng Lee, Pinar Karacabey, Rükan Genç
Opublikowane w: ACS Pharmacology & Translational Science, Numer 9, 2026, ISSN 2575-9108
Wydawca: American Chemical Society (ACS)
DOI: 10.1021/ACSPTSCI.5C00719